NEURO2026

Chairperson: Kenjiro Ono (Kanazawa University Graduate School of Medical Science　　Department of Neurology　　Professor)

Co-hosted by ONO PHARMACEUTICAL CO., LTD.

This lecture will provide a broad overview of the current landscape of Parkinson’s disease therapy, from symptomatic treatments used in daily clinical practice to future disease-modifying approaches. It will cover recent advances in levodopa therapy, continuous drug delivery, and device-aided treatments including DBS, as well as emerging strategies targeting α-synuclein, mitochondrial dysfunction, and gene and cell-based therapies. Beyond improving motor symptoms, the lecture will also focus on how treatment strategies are evolving to address non-motor symptoms, advanced-stage disease, and quality of life, and will discuss the future direction of Parkinson’s disease care.